# Relationship between vascular endothelial growth factor gene polymorphisms and Crimean–Congo hemorrhagic fever

## TL;DR

This study explores how genetic variations in the vascular endothelial growth factor gene may influence susceptibility to Crimean–Congo hemorrhagic fever.

## Contribution

The study identifies specific gene polymorphisms potentially linked to increased risk of Crimean–Congo hemorrhagic fever.

## Key findings

- Significant differences were found in VEGF −460 C/T and -ID (18 bp) polymorphisms between patients and controls.
- VEGF gene polymorphisms may contribute to genetic susceptibility to Crimean–Congo hemorrhagic fever.

## Abstract

This study aims to investigate the relationship between vascular endothelial growth factor gene polymorphisms and Crimean–Congo hemorrhagic fever

A total of 130 serum samples were analyzed, including 60 patients diagnosed with Crimean–Congo hemorrhagic fever and 70 healthy controls. Genetic analyses were performed using polymerase chain reaction and restriction fragment length polymorphism techniques.

Significant differences were observed between patient and control groups in terms of vascular endothelial growth factor −460 C/T and -ID (18 bp) polymorphisms.

Vascular endothelial growth factor gene polymorphisms may contribute to genetic susceptibility to Crimean–Congo hemorrhagic fever. Further studies with larger sample sizes are recommended to support these findings.